Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Photodynamic Therapy Global Market Report 2023. (Just out)

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on Mar 31, 2023 1:49pm

184 Views

Post# 35372287

RE:Photodynamic Therapy Global Market Report 2023. (Just out)

Wow. This article reads like a fifth-grade book report.
Nothing much in it, except a clear indication that the market is ready to accept effective photodynamic therapy.
Also, if my guess is right, and the article's author is Chinese, then the Chinese market may be hungry for effective PDT, too. Our methodology fits well with the non-invasive, Buddhist approach to medicine.
GLTA!

<< Previous

Bullboard Posts

Next >>

Full Circle Lithium goes global with its battery fire-fighter